Herbas VPB

Print
EN | LT
LT - COMBINED USE OF A SULFATED GLYCOSAMINOGLYCAN AND A HYALURONIDASE FOR IMPROVING THE BIOAVAILABILITY OF FACTOR VIII
EN - COMBINED USE OF A SULFATED GLYCOSAMINOGLYCAN AND A HYALURONIDASE FOR IMPROVING THE BIOAVAILABILITY OF FACTOR VIII

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/37
A61K 47/36
A61K 38/47
A61K 47/42
A61K 47/26
European patent
(11) Number of the document 2768521
(13) Kind of document T
(96) European patent application number 12772969.7
Date of filing the European patent application 2012-10-18
(97) Date of publication of the European application 2014-08-27
(45) Date of publication and mention of the grant of the patent 2016-07-13
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2012/070620
Date 2012-10-18
PCT application publication
(87) Number WO 2013/057171
Date 2013-04-25
Priority applications
(30) Number Date Country code
11185650 2011-10-18 EP
201161548612 P 2011-10-18 US
Inventors
(72)
ZOLLNER, Sabine, CH
METZNER, Hubert, DE
Grantee
(73) CSL Behring GmbH, Emil-von-Behring-Strasse 76, 35041 Marburg, DE
Title
(54) COMBINED USE OF A SULFATED GLYCOSAMINOGLYCAN AND A HYALURONIDASE FOR IMPROVING THE BIOAVAILABILITY OF FACTOR VIII
  COMBINED USE OF A SULFATED GLYCOSAMINOGLYCAN AND A HYALURONIDASE FOR IMPROVING THE BIOAVAILABILITY OF FACTOR VIII
Last update date 2021-04-30